| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.16 | 7e-08 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | 0.18 | 8e-07 |
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | 0.16 | 3e-06 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.15 | 4e-06 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | 0.15 | 5e-05 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | 0.13 | 5e-05 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | 0.15 | 6e-05 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | 0.15 | 7e-05 |
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | 0.14 | 7e-05 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.14 | 7e-05 |